| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.81 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |